Andrew Kenneth William Powell Aclaris Therapeutics, Inc. (ACRS) insider trading activity

Andrew Kenneth William Powell is Director of Aclaris Therapeutics, Inc.. Currently has a direct ownership of 28,863 shares of ACRS, which is worth approximately $29,728. The most recent transaction as insider was on Mar 04, 2024, when has been sold 6,000 shares (Common Stock) at a price of $1.25 per share, resulting in proceeds of $7,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K

26.24% 3M change

100.95% 12M change

Total Value Held $29,728

Andrew Kenneth William Powell Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 04 2024	BUY Open market or private purchase	$7,500 $1.25 p/Share	6,000 Added 17.21%	28,863 Common Stock
Mar 01 2024	BUY Open market or private purchase	$10,455 $1.23 p/Share	8,500 Added 27.1%	22,863 Common Stock
Jun 02 2023	BUY Exercise of conversion of derivative security	-	4,507 Added 23.88%	14,363 Common Stock
Nov 08 2022	SELL Bona fide gift	-	4,000 Reduced 28.87%	9,856 Common Stock
Jun 03 2022	BUY Exercise of conversion of derivative security	-	3,356 Added 19.5%	13,856 Common Stock
May 16 2022	SELL Bona fide gift	-	709 Reduced 6.33%	10,500 Common Stock
Nov 23 2021	SELL Bona fide gift	-	5,500 Reduced 32.92%	11,209 Common Stock

Also insider at

LNDC

LANDEC CORP \CA\ Healthcare

Director

SBTX

Silverback Therapeutics, Inc. Healthcare

Director

AKW